Brief: Eurneffy Approved In The EU

ARS Pharmaceuticals

26/08/2024 14:31

Aug 26 (Reuters) - ARS Pharmaceuticals Inc  SPRY.O :
    * EURNEFFY (ADRENALINE NASAL SPRAY) APPROVED IN THE EU AS
THE
FIRST AND ONLY NEEDLE-FREE EMERGENCY TREATMENT OF ALLERGIC
REACTIONS (ANAPHYLAXIS)
    * ARS PHARMACEUTICALS INC - ANTICIPATES THAT EURNEFFY WILL
BE MADE
AVAILABLE TO PATIENTS IN CERTAIN EUROPEAN UNION MEMBER STATES IN
Q4 2024
    * ARS PHARMACEUTICALS- ANTICIPATES EURNEFFY WILL BE MADE
AVAILABLE
TO PATIENTS IN CERTAIN EUROPEAN UNION MEMBER STATES IN Q4 2024

Source text for Eikon:  ID:nGNX4fYvyd 
Further company coverage:  SPRY.O 

 ((Reuters.Briefs@thomsonreuters.com;))